TY - GEN AB - There is an urgent unmet need for short-term interventions to prevent infection in infants exposed to HIV-1 at birth, who have higher mortality rates than infants infected at an older age. Although passively administered antibodies disperse into tissues more slowly than antiretroviral drugs (ART), potent broadly neutralizing monoclonal antibodies (bNAbs) are an attractive approach for post-exposure prophylaxis because of their longer half-life, good safety profile, and the potential for opsonization and Fc-mediated killing of infected cells. AU - Shapiro, Mariya B. DA - 2020 DO - 10.6083/st74cr11p DO - DOI ID - 8556 KW - Broadly Neutralizing Antibodies KW - HIV-1 KW - Post-Exposure Prophylaxis KW - Macaca mulatta KW - monoclonal antibodies KW - newborn infant L1 - https://digitalcollections.ohsu.edu/record/8556/files/Shapiro.Mariya.2020.pdf L2 - https://digitalcollections.ohsu.edu/record/8556/files/Shapiro.Mariya.2020.pdf L4 - https://digitalcollections.ohsu.edu/record/8556/files/Shapiro.Mariya.2020.pdf LK - https://digitalcollections.ohsu.edu/record/8556/files/Shapiro.Mariya.2020.pdf N2 - There is an urgent unmet need for short-term interventions to prevent infection in infants exposed to HIV-1 at birth, who have higher mortality rates than infants infected at an older age. Although passively administered antibodies disperse into tissues more slowly than antiretroviral drugs (ART), potent broadly neutralizing monoclonal antibodies (bNAbs) are an attractive approach for post-exposure prophylaxis because of their longer half-life, good safety profile, and the potential for opsonization and Fc-mediated killing of infected cells. PB - Oregon Health and Science University PY - 2020 T1 - Broadly neutralizing antibody therapy as post-exposure prophylaxis in a nonhuman primate model of perinatal HIV infection TI - Broadly neutralizing antibody therapy as post-exposure prophylaxis in a nonhuman primate model of perinatal HIV infection UR - https://digitalcollections.ohsu.edu/record/8556/files/Shapiro.Mariya.2020.pdf Y1 - 2020 ER -